About lanreotide + pfs
Long-acting somatostatin analogue
Used for
- Acromegaly when surgery or radiotherapy is unsuitable or insufficient.
- Symptoms of neuroendocrine tumours, including carcinoid syndrome.
- Certain gastroenteropancreatic neuroendocrine tumours, to slow tumour growth.
Usual adult dose
Usually injected under the skin every 28 days; dose and interval depend on the condition and response.
Common side effects
- Diarrhoea, abdominal pain, nausea, or vomiting.
- Gallstones or gallbladder inflammation.
- Injection-site pain or reaction.
- Changes in blood glucose or thyroid function.
Important warnings
- Can cause gallstones and affect gallbladder function.
- May alter blood sugar; monitoring may be needed.
- May slow heart rate or affect thyroid function.
- Use caution with diabetes, heart problems, or gallbladder disease.
Pregnancy
Limited information; use during pregnancy only when clearly necessary and prescribed by a specialist.
Breastfeeding
Unknown whether lanreotide passes into breast milk; breastfeeding is generally not recommended during treatment.
Interactions
- May increase effects of insulin or diabetes medicines.
- May affect heart-rate-lowering medicines, such as beta blockers.
- Can alter absorption of some medicines, including ciclosporin.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.